Cerity Partners’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-452
Closed -$1.25M 2006
2023
Q1
$1.25M Buy
+452
New +$19.3K ﹤0.01% 891
2022
Q3
Sell
-4,068
Closed -$200K 1279
2022
Q2
$200K Buy
+4,068
New +$218K ﹤0.01% 1083
2022
Q1
Sell
-4,042
Closed -$212K 1144
2021
Q4
$212K Buy
+4,042
New +$220K ﹤0.01% 914
2020
Q4
Sell
-221,388
Closed -$10.8M 661
2020
Q3
$10.8M Hold
221,388
0.44% 46
2020
Q2
$12.3M Hold
221,388
0.68% 23
2020
Q1
$11.2M Buy
221,388
+19,148
+9% +$1.28M 0.71% 21
2019
Q4
$15.6M Sell
202,240
-37,353
-16% -$2.64M 0.8% 22
2019
Q3
$15.2M Sell
239,593
-793
-0.3% -$49.6K 0.89% 18
2019
Q2
$14.1M Buy
240,386
+39,334
+20% +$2.32M 0.89% 19
2019
Q1
$11.4M Buy
201,052
+191,432
+1,990% +$10.2M 0.77% 25
2018
Q4
$477K Sell
9,620
-4
-0% -$241 0.03% 325
2018
Q3
$683K Sell
9,624
-5,471
-36% -$348K 0.05% 291
2018
Q2
$787K Buy
15,095
+5,415
+56% +$284K 0.06% 262
2018
Q1
$505K Sell
9,680
-25,319
-72% -$1.28M 0.04% 329
2017
Q4
$2.05M Sell
34,999
-20,524
-37% -$1.16M 0.14% 157
2017
Q3
$3.08M Buy
55,523
+28,946
+109% +$1.92M 0.22% 103
2017
Q2
$2.29M Buy
+26,577
New +$1.99M 0.19% 101

Other funds holding NUVA

Cerity Partners's NUVA Position: Q2 2023 in Review

Cerity Partners sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 452 shares — an estimated $1.25M sold.

Cerity Partners first reported a position in NUVA in Q2 2017 and held it in 17 quarters. The position peaked at $15.6M in Q4 2019. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

  • Cerity Partners reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
  • Cerity Partners sold 452 NuVasive, Inc. shares in Q2 2023, an estimated $1.25M.
  • Cerity Partners first reported a position in NuVasive, Inc. in Q2 2017 and held it in 17 quarters.
  • Cerity Partners's NuVasive, Inc. position peaked at $15.6M in Q4 2019.
  • 228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on Cerity Partners's 13F filing for Q2 2023, filed 14 Aug 2023.